Tachyon Ventures invests in early-stage life sciences ventures at the forefront of medicine, biotech and bioengineering. We seek scientific teams pursuing ambitious goals, backed by world-leading research (and secured IP) in the fields of immunotherapy, gene therapy / genetic engineering, organ engineering, and stem cell / regenerative medicine. We provide funding at pre-seed, seed and series A stage for teams with a robust product prototype, encouraging early test results, and a clear path-to-market.